ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (59)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Di Stefano, A.
Right arrow Articles by Adcock, I.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Di Stefano, A.
Right arrow Articles by Adcock, I.M.
Eur Respir J 2002; 20:556-563
Copyright ©ERS Journals Ltd 2002


Increased expression of nuclear factor-{kappa}B in bronchial biopsies from smokers and patients with COPD

A. Di Stefano1, G. Caramori2, T. Oates2, A. Capelli1, M. Lusuardi1, I. Gnemmi1, F. Ioli1, K.F. Chung2, C.F. Donner1, P.J. Barnes2 and I.M. Adcock2

1 Salvatore Maugeri Foundation, IRCCS, Medical Centre of Rehabilitation, Division of Pulmonary Disease, Veruno, Italy. 2 Dept of Thoracic Medicine, National Heart and Lung Institute, Imperial College School of Medicine, London, UK

CORRESPONDENCE: I.M. Adcock, Dept of Thoracic Medicine, National Heart and Lung Institute, Imperial College School of Medicine, Dovehouse Street, London, SW3 6LY, UK. Fax: 44 2073518126. E-mail: ian.adcock@ic.ac.uk

Keywords: airflow limitation, airway inflammation, nuclear factor-{kappa}B, T-lymphocytes

Received: August 13, 2001
Accepted March 28, 2002

This study was supported by the Associazione per la Ricerca e la Cura dell'Asma (ARCA, Padua, Italy), Salvatore Maugeri Foundation, IRCCS, "Ricerca Corrente" and Glaxo-Wellcome (UK).

The expression of nuclear factor (NF)-{kappa}B is an indicator of cellular activation and of inflammatory mediator production. The aim of the present study was to characterise the expression and localisation of p65, the major subunit of NF-{kappa}B, in the bronchial mucosa of patients with chronic obstructive pulmonary disease (COPD), and to examine the relationship between p65 expression and disease status.

Bronchial biopsies were obtained from 14 smokers with COPD, 17 smokers with normal lung function and 12 nonsmokers with normal lung function. The number of p65 positive (+) cells was quantified by immunohistochemistry and the expression of p65 in bronchial biopsies from the three groups was examined by Western blotting (WB).

Smokers with normal lung function and patients with COPD had increased numbers of p65+ cells in the epithelium and increased p65 nuclear expression. In COPD patients the number of epithelial p65+ cells correlated with the degree of airflow limitation. WB analysis showed an increase in p65 in smokers with normal lung function and COPD patients (p<0.05).

Bronchial biopsies in smokers with normal lung function and chronic obstructive pulmonary disease patients show increased expression of p65 protein, predominantly in the bronchial epithelium. Disease severity is associated with an increased epithelial expression of nuclear factor-{kappa}B.




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Ying, B. O'Connor, J. Ratoff, Q. Meng, C. Fang, D. Cousins, G. Zhang, S. Gu, Z. Gao, B. Shamji, et al.
Expression and Cellular Provenance of Thymic Stromal Lymphopoietin and Chemokines in Patients with Severe Asthma and Chronic Obstructive Pulmonary Disease
J. Immunol., August 15, 2008; 181(4): 2790 - 2798.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
K. F. Chung and I. M. Adcock
Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
Eur. Respir. J., June 1, 2008; 31(6): 1334 - 1356.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S.-R. Yang, S. Valvo, H. Yao, A. Kode, S. Rajendrasozhan, I. Edirisinghe, S. Caito, D. Adenuga, R. Henry, G. Fromm, et al.
IKK{alpha} Causes Chromatin Modification on Pro-Inflammatory Genes by Cigarette Smoke in Mouse Lung
Am. J. Respir. Cell Mol. Biol., June 1, 2008; 38(6): 689 - 698.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. T. Stathopoulos, T. P. Sherrill, D.-S. Cheng, R. M. Scoggins, W. Han, V. V. Polosukhin, L. Connelly, F. E. Yull, B. Fingleton, and T. S. Blackwell
Epithelial NF-{kappa}B activation promotes urethane-induced lung carcinogenesis
PNAS, November 20, 2007; 104(47): 18514 - 18519.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
T. Yoshida and R. M. Tuder
Pathobiology of Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease
Physiol Rev, July 1, 2007; 87(3): 1047 - 1082.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T. H. Thatcher, S. B. Maggirwar, C. J. Baglole, H. F. Lakatos, T. A. Gasiewicz, R. P. Phipps, and P. J. Sime
Aryl Hydrocarbon Receptor-Deficient Mice Develop Heightened Inflammatory Responses to Cigarette Smoke and Endotoxin Associated with Rapid Loss of the Nuclear Factor-{kappa}B Component RelB
Am. J. Pathol., March 1, 2007; 170(3): 855 - 864.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
I. Rahman and I. M. Adcock
Oxidative stress and redox regulation of lung inflammation in COPD.
Eur. Respir. J., July 1, 2006; 28(1): 219 - 242.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. J. Barnes, B. Chowdhury, S. A. Kharitonov, H. Magnussen, C. P. Page, D. Postma, and M. Saetta
Pulmonary Biomarkers in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., July 1, 2006; 174(1): 6 - 14.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. Szulakowski, A. J. L. Crowther, L. A. Jimenez, K. Donaldson, R. Mayer, T. B. Leonard, W. MacNee, and E. M. Drost
The Effect of Smoking on the Transcriptional Regulation of Lung Inflammation in Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., July 1, 2006; 174(1): 41 - 50.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
E. Marian, S. Baraldo, A. Visentin, A. Papi, M. Saetta, L. M. Fabbri, and P. Maestrelli
Up-Regulated Membrane and Nuclear Leukotriene B4 Receptors in COPD
Chest, June 1, 2006; 129(6): 1523 - 1530.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. Vlahos, S. Bozinovski, J. E. Jones, J. Powell, J. Gras, A. Lilja, M. J. Hansen, R. C. Gualano, L. Irving, and G. P. Anderson
Differential protease, innate immunity, and NF-{kappa}B induction profiles during lung inflammation induced by subchronic cigarette smoke exposure in mice
Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L931 - L945.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. J. Barnes
Corticosteroid effects on cell signalling
Eur. Respir. J., February 1, 2006; 27(2): 413 - 426.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. J. Barnes
Reduced Histone Deacetylase in COPD: Clinical Implications
Chest, January 1, 2006; 129(1): 151 - 155.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
A Bourbia, M A Cruz, and H J Rozycki
NF-{kappa}B in tracheal lavage fluid from intubated premature infants: association with inflammation, oxygen, and outcome
Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2006; 91(1): F36 - F39.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
W. MacNee
Pathogenesis of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, November 1, 2005; 2(4): 258 - 266.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
P. J. Barnes
Theophylline in Chronic Obstructive Pulmonary Disease: New Horizons
Proceedings of the ATS, November 1, 2005; 2(4): 334 - 339.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. M. Lora, D. M. Zhang, S. M. Liao, T. Burwell, A. M. King, P. A. Barker, L. Singh, M. Keaveney, J. Morgenstern, J. C. Gutierrez-Ramos, et al.
Tumor Necrosis Factor-{alpha} Triggers Mucus Production in Airway Epithelium through an I{kappa}B Kinase {beta}-dependent Mechanism
J. Biol. Chem., October 28, 2005; 280(43): 36510 - 36517.
[Abstract] [Full Text] [PDF]


Home page
ERRHome page
P. J. Barnes
New approaches to COPD
Eur. Respir. Rev., September 1, 2005; 14(94): 2 - 11.
[Abstract] [Full Text] [PDF]


Home page
ERRHome page
W. MacNee
Treatment of stable COPD: antioxidants
Eur. Respir. Rev., September 1, 2005; 14(94): 12 - 22.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
S. L. Johnston
Overview of Virus-induced Airway Disease
Proceedings of the ATS, August 1, 2005; 2(2): 150 - 156.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. A. Birrell, S. Wong, D. J. Hele, K. McCluskie, E. Hardaker, and M. G. Belvisi
Steroid-resistant Inflammation in a Rat Model of Chronic Obstructive Pulmonary Disease Is Associated with a Lack of Nuclear Factor-{kappa}B Pathway Activation
Am. J. Respir. Crit. Care Med., July 1, 2005; 172(1): 74 - 84.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. J. Barnes and R. A. Stockley
COPD: current therapeutic interventions and future approaches
Eur. Respir. J., June 1, 2005; 25(6): 1084 - 1106.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
W. MacNee
Pulmonary and Systemic Oxidant/Antioxidant Imbalance in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, April 1, 2005; 2(1): 50 - 60.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. J. Barnes
Mediators of Chronic Obstructive Pulmonary Disease
Pharmacol. Rev., December 1, 2004; 56(4): 515 - 548.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. A. Marwick, P. A. Kirkham, C. S. Stevenson, H. Danahay, J. Giddings, K. Butler, K. Donaldson, W. MacNee, and I. Rahman
Cigarette Smoke Alters Chromatin Remodeling and Induces Proinflammatory Genes in Rat Lungs
Am. J. Respir. Cell Mol. Biol., December 1, 2004; 31(6): 633 - 642.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
T. Harju, R. Kaarteenaho-Wiik, R. Sirvio, P. Paakko, J.D. Crapo, T.D. Oury, Y. Soini, and V.L. Kinnula
Manganese superoxide dismutase is increased in the airways of smokers' lungs
Eur. Respir. J., November 1, 2004; 24(5): 765 - 771.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
N.C. Thomson, R. Chaudhuri, and E. Livingston
Asthma and cigarette smoking
Eur. Respir. J., November 1, 2004; 24(5): 822 - 833.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
P. Chanez, A. Bourdin, I. Vachier, P. Godard, J. Bousquet, and A. M. Vignola
Effects of Inhaled Corticosteroids on Pathology in Asthma and Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, November 1, 2004; 1(3): 184 - 190.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
R. P. Schleimer
Glucocorticoids Suppress Inflammation but Spare Innate Immune Responses in Airway Epithelium
Proceedings of the ATS, November 1, 2004; 1(3): 222 - 230.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
B. G. Cosio, L. Tsaprouni, K. Ito, E. Jazrawi, I. M. Adcock, and P. J. Barnes
Theophylline Restores Histone Deacetylase Activity and Steroid Responses in COPD Macrophages
J. Exp. Med., September 7, 2004; 200(5): 689 - 695.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. Di Stefano, A. Capelli, and C. F. Donner
Role of Interleukin-8 in the Pathogenesis and Treatment of COPD
Chest, September 1, 2004; 126(3): 676 - 678.
[Full Text] [PDF]


Home page
Eur Respir JHome page
A. Di Stefano, G. Caramori, A. Capelli, I. Gnemmi, F.L. Ricciardolo, T. Oates, C.F. Donner, K.F. Chung, P.J. Barnes, and I.M. Adcock
STAT4 activation in smokers and patients with chronic obstructive pulmonary disease
Eur. Respir. J., July 1, 2004; 24(1): 78 - 85.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P.J. Barnes, S.D. Shapiro, and R.A. Pauwels
Chronic obstructive pulmonary disease: molecular and cellularmechanisms
Eur. Respir. J., October 1, 2003; 22(4): 672 - 688.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the European Respiratory Society.